Admission triglyceride-glucose index is predictor of long-term mortality and appropriate implantable cardiac defibrillator therapy in patients with heart failure.
Biomark Med
; 17(10): 487-496, 2023 05.
Article
em En
| MEDLINE
| ID: mdl-37522225
ABSTRACT
Background:
In this study, the main aim was to evaluate the relation of the triglyceride-glucose (TyG) index to long-term mortality and proper shock therapy in patients with an implantable cardiac defibrillator (ICD) implanted for heart failure with reduced ejection fraction.Methods:
This retrospective study group consisted of 773 patients treated with ICD for heart failure with reduced ejection fraction. The long-term prognostic effect of the TyG index among tertiles was evaluated regarding mortality and appropriate ICD therapy.Results:
In the adjusted model, the mortality rates were 14.0% (hazard ratio 2.24; 95% CI 1.42-6.88) in tertile 2 and 23.3% (hazard ratio 3.88; 95% CI 1.84-14.38) in tertile 3.Conclusion:
The TyG index was found to be an independent predictive marker for both long-term mortality and appropriate ICD therapy.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Desfibriladores Implantáveis
/
Insuficiência Cardíaca
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article